Welcome to Pharma Transfer
Pharma Transfer, widely recognised as the most comprehensive source of research and business development opportunities for the international pharmaceutical market, sources hundreds of new opportunities every week that specifically match the needs of our subscribers. Our opportunities come directly from pharmaceutical and biotechnology companies, government agencies, research institutes and academia encompassing all areas of pipeline development, from early-stage discovery, through pre-clinical and clinical trials, to registered products that are all available for co-development or licensing.
Since our conception in 1998 we actively source, update and remove abstracts, and are currently publishing nearly 20,000 unique opportunities from over 2,500 organisations spanning across 100 countries. Pharma Transfer grants subscribers the benefits generated from an experienced scientific staff selecting, editing and creating a structured abstract that allows concise assessment and evaluation. The abstracts include full contact details and are delivered weekly, individualized for each subscriber, based on their uniquely specific needs.
Pharma Transfer subscribers are corporate business developers, licensing executives or researchers responsible for moving the molecule to market. They benefit from our technology transfer officers consultative approach that meets their needs for research on new pharmacological compounds and enabling technologies available for licensing or partnering.Please contact us about a demonstration.
Or call us:
+44 1904 435 190 (UK) or 813-305-1460 (USA)